Rostgaard, K.
, Hamilton-Dutoit, S., Lauridsen, K. L., Ottander, L., Plesner, T. L., Hollander, P., Brown, P., Sjö, L., Johansen, C.
, Kamper, P., Høgdall, E.
, d'Amore, F., Specht, L., Jarrett, R. F., McKay, J. D., Hutchings, M., Hjalgrim, L. L., Glimelius, I. & Hjalgrim, H. (2026).
Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases.
International Journal of Cancer,
158(10), 2629-2640.
https://doi.org/10.1002/ijc.70305Sørensen, J. F., Kristensen, D. T., Ørskov, A. D., Hansen, D. L.
, Aggerholm, A., Grønbæk, K.
, Roug, A. S. & Ludvigsen, M. (2025).
A Danish nationwide population-based cohort study on acute myeloid leukemia with RUNX1::RUNX1T1 - Real-world outcomes and clinicopathological characteristics.
Blood Cancer Journal,
15(1), Article 171.
https://doi.org/10.1038/s41408-025-01377-8
Pedersen, M. N., Hybel, T. E., Bjerre, J. H., Hammer, A. S. B., Bohn, A. B., Bill, M., Rosenberg, C. A. & Ludvigsen, M. (2025).
High-Efficiency Enrichment of Megakaryocytes and Identification of Micromegakaryocytes from Human Bone Marrow by Imaging Flow Cytometry.
Cells,
14(8), Article 588.
https://doi.org/10.3390/cells14080588
Andersen, M. D., Enemark, M. H., Lauridsen, K. L., Hamilton-Dutoit, S. J., Starklint, J., d’Amore, F., Ludvigsen, M. & Kamper, P. (2025).
Lymph node transcriptomic profiles suggest susceptibility to bleomycin-induced pulmonary toxicity in classic hodgkin lymphoma.
Scientific Reports,
15(1), Article 30273.
https://doi.org/10.1038/s41598-025-16218-8
Eyre, T. A., Cwynarski, K.
, d’Amore, F., de Leval, L., Dreyling, M., Eichenauer, D. A., Ferreri, A. J. M., Giné, E., Kersten, M. J., Ladetto, M., Specht, L., Thieblemont, C., Walewski, J., Zucca, E. & Jerkeman, M. (2025).
Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Annals of Oncology,
36(11), 1263-1284.
https://doi.org/10.1016/j.annonc.2025.07.014d'Amore, F., Federico, M., de Leval, L., Ellin, F., Hermine, O., Kim, W. S., Lemonnier, F., Vermaat, J. S. P., Wulf, G., Buske, C., Dreyling, M., Jerkeman, M., ESMO Guidelines Committees & EHA Guidelines Committees (2025).
Peripheral T- and natural killer-cell lymphomas: ESMO–EHA Clinical Practice Guideline for diagnosis, treatment and follow-up ☆.
Annals of Oncology,
36(6), 626-644.
https://doi.org/10.1016/j.annonc.2025.01.023
d'Amore, F., Federico, M., de Leval, L., Ellin, F., Hermine, O., Kim, W. S., Lemonnier, F., Vermaat, J. S. P., Wulf, G., Buske, C., Dreyling, M., Jerkeman, M. & the ESMO and EHA Guidelines Committees (2025).
Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-up.
HemaSphere,
9(5), Article e70128.
https://doi.org/10.1002/hem3.70128
Andersen, M. D., Wolter, K., Enemark, M. H., Lauridsen, K. L., Hamilton-Dutoit, S. J., Starklint, J., d’Amore, F., Ludvigsen, M., Honoré, B. & Kamper, P. (2025).
Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity.
Leukemia & Lymphoma,
66(4), 656-667.
https://doi.org/10.1080/10428194.2024.2434170
Hemmingsen, J. K., Enemark, M. B. H., Sørensen, E. F., Dohrmann, C., Lauridsen, K. L., Hamilton-Dutoit, S. J., Kridel, R.
, Honoré, B. & Ludvigsen, M. (2025).
Proteomic Profiling of Limited-Stage Follicular Lymphoma Reveals Differentially Expressed Proteins Linked to Disease Progression Post-Radiation Therapy.
International Journal of Molecular Sciences (Online),
26(19), Article 9306.
https://doi.org/10.3390/ijms26199306
Andersen, M. D., Wolter, K., Enemark, M. B. H., Pedersen, M. A., Gormsen, L. C., Lauridsen, K. L., Starklint, J., Hamilton-Dutoit, S. J., d'Amore, F., Ludvigsen, M., Honoré, B. & Kamper, P. (2025).
Proteomic Profiling of Lymph Nodes Differentiates Classic Hodgkin Lymphoma With and Without Skeletal Involvement.
European Journal of Haematology, Supplement,
114(1), 173-185.
https://doi.org/10.1111/ejh.14326
Haraldsdóttir, H., Brøndum, R. F.
, Enemark, M. B. H., Honoré, B., Ludvigsen, M., Aboo, C., Stensballe, A.
, Jørgensen, J. M., Due, H. & Dybkær, K. (2025).
Proteomic Study of Diffuse Large B-Cell Lymphoma Identifying Proteins Associated with R-CHOP Response.
Biomedicines,
13(11), Article 2709.
https://doi.org/10.3390/biomedicines13112709Hemmingsen, J. K., Enemark, M. H., Pedersen, A. K., Sørensen, E. F., Lauridsen, K. L., Løhde, J. B., d’Amore, F., Hamilton-Dutoit, S. J., Bjerre, M. & Ludvigsen, M. (2025).
Reduced Activity of Soluble Fibroblast Activation Protein (sFAP) Represents a Biomarker of Aggressive Disease in Lymphoid Malignancies.
International Journal of Molecular Sciences ,
26(23), Article 11248.
https://doi.org/10.3390/ijms262311248
Ludvigsen, L. U. P., Åsberg, A., Spetalen, S., Sørensen, M. D.
, Hamilton-Dutoit, S., Gramkow, A. M.
, Christiansen, C. F., Kro, G. B.
, Thomsen, M. K., Ulrichsen, S. P., Pedersen, R. M., Holte, H., Thiesson, H. C., Bjerre, A.
, D'Amore, F., Dahle, D. O.
, Jespersen, B., Jensen-Fangel, S. & Reisæter, A. V. (2025).
Risk and prognosis of posttransplant lymphoproliferative disease in Epstein-Barr virus-seronegative kidney transplant recipients: an observational cohort study from Norway and western Denmark.
American Journal of Transplantation,
25(7), 1547-1560.
https://doi.org/10.1016/j.ajt.2025.01.035
Andersen, M. D., Wolter, K., Enemark, M. H.
, Pedersen, M. A., Gormsen, L. C., Lauridsen, K. L., Starklint, J., Hamilton-Dutoit, S. J., d'Amore, F., Ludvigsen, M. & Kamper, P. (2025).
Tumor-associated macrophages: potential role in skeletal involvement in classic Hodgkin lymphoma.
Journal of Pathology: Clinical Research,
11(4), Article e70038.
https://doi.org/10.1002/2056-4538.70038
MacManus, M. P., Seymour, J. F., Tsang, H., Fisher, R., Keane, C., Sabdia, M. B., Law, S. C., Gunawardana, J., Nath, K., Kazakoff, S. H., Marques-Piubelli, M. L., Duenas, D. E., Green, M. R., Roos, D., O'Brien, P., McCann, A., Tsang, R., Davis, S., Christie, D. ... Tobin, J. W. D. (2024).
Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma.
EBioMedicine,
110, Article 105468.
https://doi.org/10.1016/j.ebiom.2024.105468Urbonavicius, S., Srinanthalogen, R., Sandermann, J., Valius, M., Kaupinis, A.
& Ludvigsen, M. (2024).
A novel view to varicose veins pathogenesis: Proteomic profiling suggests a pivotal role of extracellular matrix degradation.
Phlebology,
39(1), 20-28.
https://doi.org/10.1177/02683555231206891
Hybel, T. E., Sørensen, E. F., Enemark, M. H., Hemmingsen, J. K., Simonsen, A. T., Lauridsen, K. L., Møller, M. B., Pedersen, C., Pedersen, G., Obel, N.
, Larsen, C. S., d'Amore, F., Hamilton-Dutoit, S., Stougaard, M., Vase, M. Ø. & Ludvigsen, M. (2024).
Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes.
AIDS,
38(14), 1897-1906.
https://doi.org/10.1097/QAD.0000000000003996
Holst, J. M., Pedersen, M. B., Enemark, M. B., Hansen, M. C., Noerhave, P. R., Plesner, T. L.
, Frederiksen, H., Moeller, M. B.
, Hamilton-Dutoit, S. J., Noergaard, P., Mortensen, B. K.
, Ommen, H. B., Stentoft, J., Tam, W.
, Ludvigsen, M., Chan, W. C.
, Birkbak, N. J., Inghirami, G.
& d’Amore, F. (2024).
Co-shared genomic alterations within tumors from patients with both myeloproliferative neoplasms and lymphoma.
Haematologica,
109(12), 4067-4072.
https://doi.org/10.3324/haematol.2023.283798
Enemark, M. H., Wolter, K., Hybel, T. E., Andersen, M. D., Sørensen, E. F., Hindkaer, L. M.
, Lauridsen, K. L., Madsen, C., Plesner, T. L., Hamilton-Dutoit, S., Honoré, B. & Ludvigsen, M. (2024).
Differential tumor protein expression at follicular lymphoma diagnosis reveals dysregulation of key molecular pathways associated with histological transformation.
Scientific Reports,
14(1), Article 29962.
https://doi.org/10.1038/s41598-024-81693-4
Shelton, V., Detroja, R., Liu, T., Isaev, K., Silva, A., Passerini, V., Bakhtiari, M., Calvente, L., Hong, M., He, M. Y., Modi, S., Hershenfeld, S. A.
, Ludvigsen, M., Madsen, C., Hamilton-Dutoit, S., d’Amore, F. A., Brodtkorb, M., Johnson, N. A., Baetz, T. ... Kridel, R. (2024).
Identification of genetic subtypes in follicular lymphoma.
Blood Cancer Journal,
14(1), Article 128.
https://doi.org/10.1038/s41408-024-01111-wHybel, T. E., Jensen, S. H., Rodrigues, M. A.
, Hybel, T. E., Pedersen, M. N., Qvick, S. H.
, Enemark, M. H., Bill, M., Rosenberg, C. A. & Ludvigsen, M. (2024).
Imaging Flow Cytometry and Convolutional Neural Network-Based Classification Enable Discrimination of Hematopoietic and Leukemic Stem Cells in Acute Myeloid Leukemia.
International Journal of Molecular Sciences ,
25(12), Article 6465.
https://doi.org/10.3390/ijms25126465
Enemark, M. H.
, Jensen, M. L., Andersen, M. D., Plesner, T. L., Hamilton-Dutoit, S. & Ludvigsen, M. (2024).
Impact of the Immune Landscape in Follicular Lymphoma: Insights into Histological Transformation in the Rituximab Era.
Cancers,
16(20), Article 3553.
https://doi.org/10.3390/cancers16203553Fischer, A., Albert, T. K., Moreno, N., Interlandi, M., Mormann, J., Glaser, S., Patil, P., de Faria, F. W., Richter, M., Verma, A., Balbach, S. T., Wagener, R., Bens, S., Dahlum, S., Göbel, C., Münter, D., Inserte, C., Graf, M., Kremer, E. ... Kerl, K. (2024).
Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas.
Nature Communications,
15(1), 8571. Article 8571.
https://doi.org/10.1038/s41467-024-52826-0Enemark, M. H., Hemmingsen, J. K., Jensen, M. L., Kridel, R.
& Ludvigsen, M. (2024).
Molecular Biomarkers in Prediction of High-Grade Transformation and Outcome in Patients with Follicular Lymphoma: A Comprehensive Systemic Review.
International Journal of Molecular Sciences ,
25(20), Article 11179.
https://doi.org/10.3390/ijms252011179
Dupuis, J., Bachy, E., Morschhauser, F., Cartron, G., Fukuhara, N., Daguindau, N., Casasnovas, R. O., Snauwaert, S., Gressin, R., Fox, C. P.
, d'Amore, F. A., Staber, P. B., Tournilhac, O., Bouabdallah, K., Thieblemont, C., André, M., Rai, S., Ennishi, D., Gkasiamis, A. ... Lemonnier, F. (2024).
Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study.
The Lancet Haematology,
11(6), e406-e414.
https://doi.org/10.1016/S2352-3026(24)00102-9Bencardino, M.
, D'Amore, F., Angot, H., Angiuli, L., Bertrand, Y., Cairns, W., Diéguez, M. C., Dommergue, A., Ebinghaus, R., Esposito, G., Komínková, K., Labuschagne, C., Mannarino, V., Martin, L., Martino, M., Neves, L. M., Mashyanov, N., Magand, O., Nelson, P. ... Pirrone, N. (2024).
Patterns and trends of atmospheric mercury in the GMOS network: Insights based on a decade of measurements.
Environmental Pollution,
363(Pt 2), Article 125104.
https://doi.org/10.1016/j.envpol.2024.125104Enemark, M. H., Hemmingsen, J. K., Andersen, M. D., Hybel, T. E., Bjørn, M. E., Josefsson, P. L., Pedersen, L. M., Juul, M. B.
, Pedersen, R. S., Thorsgaard, M.
, Sillesen, I. B., Plesner, T. L.
, Hamilton-Dutoit, S. J., Jensen, P.
, Madsen, C. & Ludvigsen, M. (2024).
Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort.
Blood Cancer Journal,
14(1), 167. Article 167.
https://doi.org/10.1038/s41408-024-01150-3
Hemmingsen, J. K., Enemark, M. H., Sørensen, E. F., Lauridsen, K. L., Hamilton-Dutoit, S. J., Kridel, R.
, Honoré, B. & Ludvigsen, M. (2024).
Proteomic Profiling Identifies Predictive Signatures for Progression Risk in Patients with Advanced-Stage Follicular Lymphoma.
Cancers,
16(19), Article 3278.
https://doi.org/10.3390/cancers16193278
Hershenfeld, S. A., Tobin, J. W. D., Shelton, V., Calvente, L., Lajkosz, K., Liu, T., Brodtkorb, M.
, d'Amore, F. A., Ludvigsen, M., Baetz, T., LeBrun, D., Johnson, N., Crump, M., Hong, M., Kuruvilla, J., Tremblay-LeMay, R., MacManus, M., Tsang, R., Hodgson, D. C. ... Kridel, R. (2024).
Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy.
British Journal of Haematology,
205(5), 1810-1814.
https://doi.org/10.1111/bjh.19698Ludvigsen, L. U. P., Andersen, A. S.
, Hamilton-Dutoit, S., Jensen-Fangel, S., Bøttger, P., Handberg, K. J., Ivarsen, P., d'Amore, F., Bibby, B. M., Albertsen, B. K., Jespersen, B. & Thomsen, M. K. (2023).
A prospective evaluation of the diagnostic potential of EBV-DNA in plasma and whole blood.
Journal of Clinical Virology,
167, Article 105579.
https://doi.org/10.1016/j.jcv.2023.105579
Leivonen, S. K., Friman, T., Autio, M., Vaittinen, S., Jensen, A. W.
, d’Amore, F., Hamilton-Dutoit, S. J., Holte, H., Beiske, K., Kovanen, P. E., Räty, R. & Leppä, S. (2023).
Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas.
Haematologica,
108(11), 3044-3057.
https://doi.org/10.3324/haematol.2023.282831Neldeborg, S., Soerensen, J. F., Møller, C. T., Bill, M., Gao, Z., Bak, R. O., Holm, K., Sorensen, B., Nyegaard, M., Luo, Y., Hokland, P., Stougaard, M., Ludvigsen, M. & Holm, C. K. (2023).
Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo.
Leukemia,
37(9), 1792-1801.
https://doi.org/10.1038/s41375-023-01950-9
Enemark, M. B. H., Sørensen, E. F., Hybel, T. E., Andersen, M. D., Madsen, C., Lauridsen, K. L., Honoré, B., d'Amore, F., Plesner, T. L.
, Hamilton-Dutoit, S. J. & Ludvigsen, M. (2023).
IDO1 Protein Is Expressed in Diagnostic Biopsies from Both Follicular and Transformed Follicular Patients.
International Journal of Molecular Sciences ,
24(8), Article 7314.
https://doi.org/10.3390/ijms24087314
Beck Enemark, M., Wolter, K., Campbell, A. J.
, Andersen, M. I. D., Sørensen, E. F., Hybel, T. E., Madsen, C., Lauridsen, K. L., Plesner, T. L., Hamilton-Dutoit, S. J., Honoré, B. & Ludvigsen, M. (2023).
Proteomics identifies apoptotic markers as predictors of histological transformation in patients with follicular lymphoma.
Blood Advances,
7(24), 7418-7432.
https://doi.org/10.1182/bloodadvances.2023011299
Ludvigsen, M., Campbell, A. J.
, Enemark, M. B., Hybel, T. E., Karjalainen-Lindsberg, M.-L., Beiske, K.
, Bjerre, M., Pedersen, L. M., Holte, H., Leppä, S.
, Jørgensen, J. M. & Honoré, B. (2023).
Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma.
Blood Cancer Journal,
13(1), Article 161.
https://doi.org/10.1038/s41408-023-00931-6
Antiga, E.
, Bech, R., Maglie, R., Genovese, G., Borradori, L., Bockle, B., Caproni, M., Caux, F., Chandran, N. S., Corrà, A.
, D'Amore, F., Daneshpazhooh, M., De, D., Didona, D., Dmochowski, M., Drenovska, K., Ehrchen, J., Feliciani, C., Goebeler, M. ... Marzano, A. V. (2023).
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV).
Journal of the European Academy of Dermatology & Venereology,
37(6), 1118-1134.
https://doi.org/10.1111/jdv.18931Hybel, T. E., Vase, M. Ø., Lauridsen, K. L., Enemark, M. B., Møller, M. B., Pedersen, C., Pedersen, G.
, Hamilton-Dutoit, S., Obel, N.
, Schade Larsen, C., d’Amore, F. & Ludvigsen, M. (2022).
CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus.
Leukemia & Lymphoma,
63(6), 1479-1483.
https://doi.org/10.1080/10428194.2021.2023741
Honoré, B., Andersen, M. D., Wilken, D., Kamper, P., d'Amore, F., Hamilton-Dutoit, S. & Ludvigsen, M. (2022).
Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling.
Cancers,
14(1), Article 247.
https://doi.org/10.3390/cancers14010247
Soerensen, J. F., Aggerholm, A., Rosenberg, C. A., Bill, M., Kerndrup, G. B.
, Ebbesen, L. H., Hansen, M. H., Roug, A. S. & Ludvigsen, M. (2022).
Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation.
Bone Marrow Transplantation,
57(3), 460-465.
https://doi.org/10.1038/s41409-022-01567-z
Herek, T. A., Bouska, A., Lone, W., Sharma, S., Amador, C., Heavican, T. B., Li, Y., Wei, Q., Jochum, D., Greiner, T. C., Smith, L., Pileri, S., Feldman, A. L., Rosenwald, A., Ott, G., Lim, S. T., Ong, C. K., Song, J., Jaffe, E. S. ... Iqbal, J. (2022).
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS.
Blood,
140(11), 1278-1290.
https://doi.org/10.1182/blood.2021015019de Leval, L., Alizadeh, A. A., Bergsagel, P. L., Campo, E., Davies, A., Dogan, A., Fitzgibbon, J., Horwitz, S. M., Melnick, A. M., Morice, W. G., Morin, R. D., Nadel, B., Pileri, S. A., Rosenquist, R., Rossi, D., Salaverria, I., Steidl, C., Treon, S. P., Zelenetz, A. D. ... Scott, D. W. (2022).
Genomic profiling for clinical decision making in lymphoid neoplasms.
Blood,
140(21), 2193-2227.
https://doi.org/10.1182/blood.2022015854Hussmann, D., Starnawska, A., Kristensen, L.
, Daugaard, I., Thomsen, A.
, Kjeldsen, T., Hansen, C. S., Bybjerg-Grauholm, J.
, Dalsgaard Johansen, K., Ludvigsen, M., Kristensen, T., Larsen, T. S., Møller, M. B., Nyvold, C. G.
, Hansen, L. L. & Wojdacz, T. K. (2022).
IGHV-associated methylation signatures more accurately predict clinical outcomes of chronic lymphocytic leukemia patients than IGHV mutation load.
Haematologica,
107(4), 877-886.
https://doi.org/10.3324/haematol.2021.278477
Rosenberg, C. A., Bill, M., Maguire, O.
, Petersen, M. A., Kjeldsen, E., Hokland, P. & Ludvigsen, M. (2022).
Imaging flow cytometry reveals a subset of TdT negative T-ALL blasts with very low forward scatter on conventional flow cytometry.
Cytometry Part B - Clinical Cytometry,
102(2), 107-114.
https://doi.org/10.1002/cyto.b.22035
Petersen, M. A., Rosenberg, C. A., Brøndum, R. F.
, Aggerholm, A., Kjeldsen, E., Rahbek, O.
, Ludvigsen, M., Hasle, H., Roug, A. S. & Bill, M. (2022).
Immunophenotypically defined stem cell subsets in paediatric AML are highly heterogeneous and demonstrate differences in BCL-2 expression by cytogenetic subgroups.
British Journal of Haematology,
197(4), 452-466.
https://doi.org/10.1111/bjh.18094
Andersen, M. I. D., Hamilton-Dutoit, S., Modvig, L.
, Vase, M., Christiansen, I., Christensen, J. H., Dahl-Sørensen, R. B., Stoltenberg, D.
, Kamper, P. & d'Amore, F. (2022).
Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma: A study from the Danish Lymphoma Registry.
British Journal of Haematology,
198(1), 50-61.
https://doi.org/10.1111/bjh.18180
Relander, T.
, Pedersen, M. B., Ellin, F., Lauritzsen, G. F., Jantunen, E., Hagberg, H., Holte, H., Österborg, A., Nully Brown, P. D., Kuittinen, O., Erlanson, M., Østenstad, B., Fagerli, U.-M., Delabie, J., Sundström, C., Sander, B.
, Hamilton-Dutoit, S. J., Ehinger, M., Liestøl, K.
... d'Amore, F. A. (2022).
Long-Term Follow-up of Clinical Outcome Determinants and Correlative Biological Features from the Nordic NLG-T-01 Trial.
Blood,
140(Supplement 1), 1479–1480.
https://doi.org/10.1182Petersen, M. A., Rosenberg, C. A., Bill, M., Enemark, M. B., Rahbek, O.
, Roug, A. S., Hasle, H., Honoré, B. & Ludvigsen, M. (2022).
Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients.
Cancers,
14(15), Article 3567.
https://doi.org/10.3390/cancers14153567